1. Preventing Heart Failure Readmission and Progression

3. Topics to Discuss

4. CMS Measures in Heart Failure 30-Day Hospital Readmission Rates

5. Systems Appropriate to the Population

6. Outpatient Management If a Patient is Not Admitted, They Can Not Be Readmitted

8. Proportions of Readmissions for Causes Other Than the Condition at Initial Discharge

9. Predictor of Rehospitalization

10. Unmet Need – Progressive Disease

13. Evidence Based Therapies and Titration

14. Socioeconomic Impact

15. Team Approach to Disease Management

16. LCZ696: Sacubitril/valsartan Angiotensin Receptor Neprilysin Inhibitor (ARNi)

17. ARNi Mechanism of Action

18. Loop Diuretics Mechanism of Action

19. Ivabradine Mechanism of Action

20. Omecamtiv Mecarbil (OM) MOA Novel Selective Cardiac Myosin Activator

21. Serelaxin RELAX-AHF

22. There is a Need for Therapies That Will Prevent Damage and Progression

23. Summary – Progressive Disease Symptoms Are Only Part of the Story

24. Summary (cont) Progress But Continued Unmet Need

25. Abbreviations

26. Abbreviations (cont)

27. References

28. References (cont)

29. References (cont)